Tag: FDA-approved TKI for pediatrics

Home / FDA-approved TKI for pediatrics

Categories

Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia

Nov 2023: For paediatric patients aged one year and above with chronic phase (CP) Ph+ chronic myelogenous leukaemia (CML), either newly diagnosed (ND) or resistant or intolerant (R/I) to previous the...
fda-approved-tki-for-pediatrics

Scan the code